These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 34268792)

  • 1. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
    Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
    J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
    Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
    Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
    Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.
    Dai D; Tan Y; Guo L; Tang A; Zhao Y
    Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
    Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
    Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
    Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
    Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
    Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
    Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and
    Kazlauskiene M; Klimaite R; Kondrotiene A; Dauksa A; Dauksiene D; Verkauskiene R; Zilaitiene B
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39125979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.
    Akyay OZ; Gov E; Kenar H; Arga KY; Selek A; Tarkun İ; Canturk Z; Cetinarslan B; Gurbuz Y; Sahin B
    OMICS; 2020 Mar; 24(3):148-159. PubMed ID: 32073999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
    Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
    Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Duan Y; Zhang Y; Peng W; Jiang P; Deng Z; Wu C
    Pharmazie; 2020 Jun; 75(6):266-270. PubMed ID: 32539923
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA Profiling in Papillary Thyroid Cancer.
    Armos R; Bojtor B; Papp M; Illyes I; Lengyel B; Kiss A; Szili B; Tobias B; Balla B; Piko H; Illes A; Putz Z; Kiss A; Toth E; Takacs I; Kosa JP; Lakatos P
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
    Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
    Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
    Li M; Song Q; Li H; Lou Y; Wang L
    PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
    Huang Y; Liao D; Pan L; Ye R; Li X; Wang S; Ye C; Chen L
    Eur J Endocrinol; 2013 May; 168(5):675-81. PubMed ID: 23416953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hsa-miR-206b Involves in the Development of Papillary Thyroid Carcinoma via Targeting LMX1B.
    Lu H; Zhu C; Ruan Y; Fan L; Ruan Z; Chen Q; Yuan J; Xu Y; Wang H; Wei Q
    Biomed Res Int; 2022; 2022():7488708. PubMed ID: 35342753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
    He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
    BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.